Data availability
No datasets were generated or analysed during the current study.
Abbreviations
- ILTAC:
-
Intralesional triamcinolone acetonide
- NP:
-
Nail psoriasis
- NAPSI:
-
Nail Psoriasis Severity Index
- NAPSIm:
-
Nail Psoriasis Severity Index matrix
- NAPSIb:
-
Nail Psoriasis Severity Index bed
- AE:
-
Adverse event
References
Rigopoulos D, Baran R, Chiheb S et al (2019) Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group consensus. J Am Acad Dermatol 81(1):228–240. https://doi.org/10.1016/j.jaad.2019.01.072
Boontaveeyuwat E, Silpa-Archa N, Danchaivijitr N, Wongpraparut C (2019) A randomized comparison of efficacy and safety of intralesional triamcinolone injection and clobetasol propionate ointment for psoriatic nails. J Dermatolog Treat 30(2):117–122. https://doi.org/10.1080/09546634.2018.1476647
Abdelmeniem IM, El Eryan IM, Nofal A, Fouda I, Omar SS (2022) Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: a comparative study. Dermatol Ther 35(9):e15660. https://doi.org/10.1111/dth.15660
Kenalog-10 Injection (triamcinolone acetonide injection suspension, USP) [package insert]. Princeton, NJ: Bristol-Myers Squibb Company.; [accessed 2023 July 28]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/012041s036,014901s037lbl.pdf
Nantel-Battista M, Richer V, Marcil I, Benohanian A (2014) Treatment of nail psoriasis with intralesional triamcinolone acetonide using a needle-free jet injector: a prospective trial. J Cutan Med Surg 18(1):38–42. https://doi.org/10.2310/7750.2013.13078
Funding
None.
Author information
Authors and Affiliations
Contributions
JWR: Methodology, Data collection, Data curation, Validation, Writing-Original draft preparation, Writing-Review and Editing; YQ: Data curation, Statistical analysis, Writing-Editing; SRL: Conceptualization, Methodology, Data collection, Validation, Writing-Original draft preparation, Writing-Review and Editing, Supervision.
Corresponding author
Ethics declarations
Ethics approval
The study was conducted according to the guidelines of the Declaration of Helsinki, approved by the Institutional Review Board of Weill Cornell Medicine (record #: 1609017586, approval date 01/08/2021), and registered on ClinicalTrials.gov (NCT03991936). This work is not under consideration at any other journal and has not been previously presented.
Consent to participante
A written informed consent was obtained from all participants included in this study.
Consent for publication
All subjects gave consent for the publication of recognizable patient photographs or other identifiable material with the understanding that this information may be publicly available.
Conflicts of interest
Dr. Jose W. Ricardo and Ms. Yuqing Qiu have no conflicts of interest relevant to the content of the submission. Dr. Lipner has served as a consultant for Ortho-Dermatologics, Moberg Pharmaceuticals, and BelleTorus Corporation.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ricardo, J.W., Qiu, Y. & Lipner, S.R. Optimizing intralesional triamcinolone acetonide treatment for isolated nail psoriasis: a pilot, intra-subject randomized controlled trial. Arch Dermatol Res 316, 113 (2024). https://doi.org/10.1007/s00403-024-02849-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00403-024-02849-w